Opioid Related Disorders

Researchers discuss new research on buprenorphine, the “gold standard” treatment for opioid use disorder at the APA Annual Meeting.

Recovery from addiction does not protect against normal life events...

Catch up on all the latest from the American Pharmacists Association (APhA) Annual Meeting & Exposition.

If you missed out on the custom Around the Practice video program on naloxone, we've got you covered. Read a recap here.

How can this combination of treatments help create positive change for individuals struggling with addiction?

Can a game improve children and adolescents knowledge of the opioid crisis?

Playing with opioids is a dangerous game...

This is the sad reality: In the first year of COVID-19, there were 20,000 more opioid overdose deaths than years previous.

A coalition of 240 organizations came together to urge Congress to pass legislation to fight the opioid crisis.

Unintentional overdose with antipsychotics plus opioids. Researchers performed a population-based cohort study of the risk of overdose associated with co-prescription of antipsychotics and opioids.

How can psychiatrists improve substance use treatment for Black and pediatric patients?

The American Medical Association is urging policymakers to act now to prevent further opioid overdose deaths.

A vaccine that prevents oxycodone from entering the brain? This might be the safe, long-lasting, cost-effective solution for opioid use disorders.

The FDA is holding a workshop to discuss mandatory opioid prescriber education through the Opioid Analgesic Risk Evaluation and Mitigation Strategy.

Are benzodiazepine prescriptions contributing to the opioid overdose epidemic?

In this journal club, a medical student and an addiction psychiatrist review a thematic analysis of successful prevention efforts in states with declining rates of opioid-related overdose deaths.

Manufactured fentanyl is a major cause of overdoses for opioids and nonopiods. Can a vaccine immunize against overdose?

After the largest increase in overdose deaths in 50 years, the American Psychiatric Association sends out the call for improved substance use care.

Novel digital therapy modia will be evaluated in combination with sublingual buprenorphine/naloxone background therapy to see whether it is superior in reducing opioid use.

The enduring racial gap in the opiate addiction rate stems largely from racist 19th-century medical beliefs about Black bodies, coupled with substandard medical care provided to Black Civil War troops.

Adial’s AD04 for the treatment of alcohol use disorder received a Notice of Allowance from the US Patent and Trademark Office.

How can understanding the opioid crisis in Canada inform strategies in the United States?

According to Nora D. Volkow, MD, Director of the National Institute on Drug Abuse, drug use and overdose deaths have significantly increased since the outset of the pandemic. What made it worse?